ChemoCentryx
CCXI
#3212
Rank
โ‚ฌ3.52 B
Marketcap
48,95ย โ‚ฌ
Share price
0.00%
Change (1 day)
34.60%
Change (1 year)

P/E ratio for ChemoCentryx (CCXI)

P/E ratio on November 25, 2022 (TTM): -27.5

According to ChemoCentryx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -27.5079. At the end of 2021 the company had a P/E ratio of -19.3.

P/E ratio history for ChemoCentryx from 2012 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2021-19.3-74.8%
2020-76.487.49%
2019-40.8184.03%
2018-14.4-189.27%
201716.1-289.06%
2016-8.5113.41%
2015-7.5018.59%
2014-6.323.76%
2013-6.09-36.49%
2012-9.60

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
9.12-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
46.5-268.98%๐Ÿ‡บ๐Ÿ‡ธ USA
10.1-136.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
14.9-154.04%๐Ÿ‡บ๐Ÿ‡ธ USA
10.8-139.40%๐Ÿ‡บ๐Ÿ‡ธ USA
21.1-176.78%๐Ÿ‡บ๐Ÿ‡ธ USA
14.1-151.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-8.56-68.90%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
54.1-296.72%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.